Stoke Therapeutics

STOK

30.0401.90% ( +0.560 )

Closed: Jul 30, 15:59:58 (EDT)

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Stoke Therapeutics(STOK) predict that the Revenue is 6.229 M (-96.07%), Beat estimate;the EBIT is -53.42 M (-148%), Beat estimate;the EPS is -0.79 (-141.6%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueExceed expectations

0.01B96.07%

0.01B96.76%

+0.00B0.69%

EBITExceed expectations

-0.05B148.02%

-0.06B149.54%

+0.00B1.52%

EPSExceed expectations

-0.79141.58%

-0.839144.16%

+0.04902.58%

Upcoming earnings report - FY2026 Q2 Earning Release

Available dateAug 3, 2026

Estimate Revenue5.09 M

Estimate EBIT-55.42 M

Estimate EPS-0.7818

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD